日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer

一种靶向TROP2和c-Met的双特异性纳米抗体-药物偶联物，用于低浓度、单剂量治疗胰腺癌

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102688
Ning, Wenjing; Liu, Han; Zeng, Hongye; Qin, Xiaojing; Xu, Lin; Yang, Shiting; Wang, Yue; Chen, Fentian; Yuan, Na; Chen, Xiaoqing; Xu, Tao; Wu, Kexin; Wang, Peng; Liu, Chao; Chen, Yuanzhi; Xia, Ningshao; Liu, Xue; Luo, Wenxin
肿瘤免疫
肿瘤
胰腺癌
发表日期：2026
文献求助 收藏

Engineering heavy chain antibody-drug conjugates against solid tumors for a one-shot kill

针对实体瘤设计重链抗体药物偶联物，实现一击必杀

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12616
Liu, Xue; Ning, Wenjing; Wang, Lei; Liu, Han; Zeng, Hongye; Qin, Xiaojing; Chen, Yuanzhi; Chen, Fentian; Xu, Lin; Zhao, Yang; Chen, Xiaoqing; Tang, Jixian; Ren, Yunlong; Yan, Xiaowen; Luo, Wenxin; Xia, Ningshao
发表日期：2024
文献求助 收藏

HBsAg and TLR7/8 dual-targeting antibody-drug conjugates induce sustained anti-HBV activity in AAV/HBV mice: a preliminary study.

HBsAg 和 TLR7/8 双靶向抗体药物偶联物在 AAV/HBV 小鼠中诱导持续的抗 HBV 活性：一项初步研究

期刊:Antibody Therapeutics
影响因子:4.5
doi:10.1093/abt/tbae016
Ye Xinya, Chen Xiaoqing, Liu Han, Jiang Yichao, Yang Chengyu, Xu Tao, Chen Ziyou, Wang Yalin, Chen Fentian, Liu Xue, Yu Hai, Yuan Quan, Xia Ningshao, Chen Yuanzhi, Luo Wenxin
其它
药物研究
发表日期：2024
文献求助 收藏

Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells

利用杂交瘤细胞中活化诱导的胞苷脱氨酶产生针对B型流感病毒的功能性抗体

期刊:Virologica Sinica
影响因子:4
doi:10.1016/j.virs.2022.03.009
Chen, Yuanzhi; Shen, Chenguang; Chen, Jing; Chen, Junyu; Chen, Fentian; Zhang, Limin; Liu, Xue; Chen, Siyuan; Xue, Sen; Liu, Yongliang; Tang, Jixian; Yuan, Quan; Chen, Yixin; Luo, Wenxin; Xia, Ningshao
微生物学
细胞生物学
流感
发表日期：2022
文献求助 收藏